Data / Form D filings / Myosin Therapeutics Inc.
Myosin Therapeutics Inc.: Form D filings
Myosin Therapeutics Inc., a pharmaceuticals company in Jupiter, FL, filed 2 Form D notices with the SEC between 2022 and 2023. The latest, on March 24, 2023, reports $3 million sold of a $3 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 130 SCRIPPS WAY, 3B3, Jupiter, FL, 33458
- Phone
- 1-844-696-7469
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1958190
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 24, 2023 | Amendment | $2,999,986 | $2,999,986 | 4 | Dec 2, 2022 | sec.gov | |
| Dec 19, 2022 | New notice | $2,499,988 | $1,499,992 | $999,996 | 1 | Dec 2, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Patrick Griffin, Ph.D. | Director | |
| Dave Adams | Director | |
| Andrew Ritter | Director | |
| Courtney Miller | Executive Officer, Director | |
| Robert Finizio | Director | |
| Theodore Kamenecka | Director | |
| Jackson Streeter | Director |
Other pharmaceuticals companies in Florida that filed recently
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Mar 20, 2023 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Myosin Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.